Suppression of cytokine release syndrome by conjugating TCR-signaling-responsive siltuximab nanogels with CAR-T cells

Chimeric antigen receptor T-cells (CAR-T) therapy has demonstrated significant anti-tumor responses in hematological malignancies and even solid tumors. However, the overactivation of CAR-T cells in vivo can lead to cytokine release syndrome (CRS), with the unpredictable timing and severity of its o...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Haimei Li, Zichen Wang, Liang Huang, Yi Liu, Peng Jiang
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Tsinghua University Press 2025-11-01
Reeks:	Nano Research
Onderwerpen:	chimeric antigen receptor t-cells (car-t) cytokine release syndrome siltuximab nanogels reductive environment tumor therapy
Online toegang:	https://www.sciopen.com/article/10.26599/NR.2025.94908075
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!